Kavitha Nagandla

ORCID: 0000-0002-2561-4872 · 2 papers in corpus

article 2023

Evaluation of Levonorgestrel-Releasing Intrauterine System (LNG) in The Management of Uterine Adenomyosis: An Update Systematic Review and Meta- Analysis

·doi:10.30699/jogcr.8.2.105

Background & Objective: Adenomyosis is a common benign endometrial disease which causes abnormal uterine bleeding in premenopausal women and affects the quality of life. The definitive treatment is hysterectomy; however, medical treatment i…

article 2014

Hormonal treatment for uterine adenomyosis

·doi:10.1002/14651858.cd011372

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of hormonal therapies for uterine adenomyosis in premenopausal women.